Main Menu

Lilly tried several product line extension strategies, including extended release formulations and paying for clinical trials to test the efficacy and safety of fluoxetine in premenstrual dysphoric disorder and rebranding the drug in that indication as sarafem after it was approved by the fda in 2000, following the recommendation...

Read More

This review article focuses on the spectrum of activity of chloramphenicol, mechanism of action , side effects , its parentral and oral use, its resistance mechanisms, toxicity elucidated by enteric pathogens against it and also on the possibility of its therapeutic use in treatment of multi – drug resistant...

Read More

Beta-blockers eg, propranolol , clonidine, disopyramide, ketolides eg, telithromycin , macrolides eg, erythromycin , or ritonavir because they may increase the risk of calan s side effects phenobarbital, rifampin, or st.

Read More